The effects of weight loss on normal transaminase levels in obese patients

American Journal of the Medical Sciences

Volumn 334, Issue 5, 2007, Pages 327-330

  Uslan, Ihsan ^a,c   Acarturk, Gursel ^a   Karaca, Esen ^b   Albayrak, Ramazan ^a   Yuksel, Seref ^a   Colbay, Mehmet ^a   Karaman, Ozcan ^a   Akcan, Yusuf ^a  

^a AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c Afyon Kocatepe Universitesi Rektorluk Ahmet Necdet Sezer Arastirma ve Uygulama Hastanesi   (Turkey)

Author keywords

Insulin resistance; Obesity; Transaminases

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; WEIGHT REDUCTION; AGED; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADULT; AGED; ALANINE TRANSAMINASE; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TRANSAMINASES; WEIGHT LOSS;

EID: 38449114917     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181557702     Document Type: Article

References (22)

1. Fan J.G. Zhu J. Li X.J. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China J Hepatol 43 2005 508 514
2. Chitturi S. Abeygunasekera S. Farrell G.C. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 497 499
3. Marchesini G. Brizi M. Morselli-Labate A. Association of non-alcoholic fatty liver disease with insulin resistance Am J Med 107 1999 450 455
4. Bonora E. Targher G. Alberiche M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity Diabetes Care 23 2000 57 63
5. Angelico F. Del Ben M. Conti R. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease J Clin Endocrinol Metab 90 2005 1578 1582
6. Palmer M. Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients Gastroenterology 99 1990 1408 1413
7. Ueno T. Sugawara H. Sujaku K. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver J Hepatol 27 1997 103 107
8. Luyckx F.H. Lefebvre P.J. Scheen A.J. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss Diabetes Metab 26 2000 98 106
9. Caldwell S.H. Hespenheide E.E. Redick J.A. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis Am J Gastroenterol 96 2001 519 525
10. Marchesini G. Brizi M. Bianchi G. Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893 894
11. Agrawal S. Bonkovsky H.L. Management of nonalcoholic steatohepatitis J Clin Gastroenterol 35 2002 253 261
12. Nakao K. Nakata K. Ohtsubo N. Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults Am J Gastroenterol 97 2002 1796 1801
13. Marchesini G. Brizi M. Bianchi G. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850
14. Park H.S. Kim M.W. Shin E.S. Effect of weight control on hepatic abnormalities in obese patients with fatty liver J Korean Med Sci 10 1995 414 421
15. Hickman I.J. Jonsson J.R. Prins J.B. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life Gut 53 2004 413 419
16. Prati D. Taioli E. Zanella A. Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 2002 1 10
17. Marchesini G. Avagnina S. Barantani E.G. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome J Endocrinol Invest 28 2005 333 339
18. Mofrad P. Contos M.J. Haque M. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 37 2003 1286 1292
19. Ikeda Y. Suehiro T. Nakamura T. Clinical significance of the insulin resistance index assessed by homeostasis model assessment Endocr J 48 2001 81 86
20. Joseph A.E. Saverymuttu S.H. al-Sam S. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease Clin Radiol J 43 1991 26 31
21. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease Gastroenterology 123 2002 1702 1704
22. Bellentani S. Saccoccio G. Masutti F. Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 2000 112 117